Clinical Trials Browser

Phase 1 × Riluzole × Dermatologic × Clear all

NCT01303341 2026-03-18

Riluzole and Sorafenib Tosylate in Treating Patients With Advanced Solid Tumors or Melanoma

Phase 1 Active not recruiting

Melanoma

NCT00667901 2009-12-11

Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Can Be Removed by Surgery

Phase 1 Terminated

Melanoma